Post by Allucent

Allucent is pleased to announce the launch of our Integrated Global Network for Innovative Trial Execution (IGNITE™). IGNITE is a performance-based clinical trial site network of pre-qualified, therapeutically aligned research sites and site networks which will include over 240 global sites across all major global regions, with access to patient populations of over 50 million individuals.   Through long-term strategic partnerships and therapeutic alignment with Allucent's Centers of Expertise (ACE), IGNITE fosters a more collaborative, efficient, and predictable approach to clinical trials.   Together with our trusted site partners and a shared commitment to quality and performance, IGNITE helps sponsors achieve both rapid FPI and sustained enrollment performance through LPI with greater predictability and reduced risk Learn more about IGNITE: https://lnkd.in/eEWpCwyS   #Allucent #BringingNewTherapiesToLight #IGNITESiteNetwork #ClinicalTrialSiteNetwork #SiteIntelligence #StudyStartUp #Feasibility